N-(1H-Benzo[d]imidazol-2-yl)-2-hydroxybenzamide

Catalog No.: 
ACIKOU875
CAS No.: 
61745-68-4
Molecular Formula: 
C14H11N3O2
Molecular Weight: 
253.26
N-(1H-Benzo[d]imidazol-2-yl)-2-hydroxybenzamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$201.00InquiryInquiry
5g95%$616.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(1H-Benzo[d]imidazol-2-yl)-2-hydroxybenzamide
IUPAC NameN-(1H-benzo[d]imidazol-2-yl)-2-hydroxybenzamide
MDL No.MFCD01666895
Molecular FormulaC14H11N3O2
Molecular Weight253.26
SMILESO=C(NC1=NC2=CC=CC=C2N1)C3=CC=CC=C3O
InChI KeyONQHWFJTDJGHAS-UHFFFAOYSA-N
SynonymN-(1H-benzimidazol-2-yl)-2-hydroxybenzamide;N-(1H-Benzo[d]imidazol-2-yl)-2-hydroxybenzamide
CAS No.61745-68-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACIKOU875 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACXKWJ601 route compound structure diagram
    ACXKWJ601934-32-7In Stock
  2. Plus
  3. ACJAND021 route compound structure diagram
    ACJAND021578-36-9In Stock
  4. Then
  5. ACIKOU875 route product structure diagram
    ACIKOU87561745-68-4
Inquiry

2. ACIKOU875 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACXKWJ601 route compound structure diagram
    ACXKWJ601934-32-7In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACIKOU875 route product structure diagram
    ACIKOU87561745-68-4
Inquiry

3. ACIKOU875 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACIKOU875 route product structure diagram
    ACIKOU87561745-68-4
Inquiry

Comments (0)